Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Inherited Mindset: Firing Your Family’s Financial Beliefs 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

The Rise of the AI Moderates 32 min · 27 Sep 2026 · The AI Daily Brief: Artificial Intelligence News and Analysis

7AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

The Sunday Paper Review 27th September 31 min · 27 Sep 2026 · The Pat Kenny Show

Danielle with… Amber Glenn and Pasha Pashkov 1h 0m · 27 Sep 2026 · Pod Meets World

Khvicha Kvaratskhelia - The Football Interview 9 min · 27 Sep 2026 · Football Daily

Report any issue

Source

Recorded29 Dec 2025

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:14949200

Show notes

Are you up to date on the evolving treatment landscape for HER2-mutated non-small cell lung cancer (NSCLC)? Do you know the role of novel targeted therapies? Credit available for this activity expires: 12/24/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/precision-oncology-her2-mutated-nsclc-strategies-today-and-2025a100105r?ecd=bdc_podcast_libsyn_mscpedu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in